Table 3.
Case No. | Gender | Age at time of surgery | Tumor Stage UICC | Tumor Stage TNM | Lymphnode metastasis ratio | IHC score of ERβ | IHC score of IL6 | ||
---|---|---|---|---|---|---|---|---|---|
Primary Tumor | Lymphnode Metastasis | Primary Tumor | Lymphnode Metastasis | ||||||
01 | Female | 48 | IIIA | pT2aN2 | 11/13 | ++ | ++ | + | – |
02 | Male | 64 | IIIA | pT2aN2 | 11/26 | + | +++ | ++ | +++ |
03 | Male | 66 | IIIA | pT2bN2 | 5/21 | ++ | +++ | ++ | +++ |
04 | Male | 21 | IIIA | pT2bN2 | 6/26 | ++ | ++ | +++ | +++ |
05 | Male | 63 | IIIA | pT2bN2 | 4/16 | ++ | ++ | ++ | ++ |
06 | Male | 57 | IIIA | pT2aN2 | 7/16 | + | +++ | ++ | +++ |
07 | Male | 46 | IIIA | pT2aN2 | 5/27 | +++ | +++ | ++ | ++ |
08 | Female | 58 | IIIB | pT3N3 | 4/14 | + | +++ | + | ++ |
09 | Male | 52 | IIIA | pT2aN2 | 5/18 | ++ | ++ | ++ | +++ |
10 | Male | 38 | IIIB | pT4N2 | 4/16 | ++ | ++ | ++ | ++ |
11 | Male | 60 | IIB | pT2bN1 | 2/40 | + | +++ | ++ | +++ |
12 | Male | 58 | IIIA | pT3N2 | 11/18 | +++ | +++ | ++ | +++ |
13 | Male | 53 | IIIB | pT2bN3 | 14/20 | ++ | +++ | ++ | +++ |
14 | Female | 57 | IIIB | pT1bN3 | 9/12 | +++ | +++ | ++ | +++ |
15 | Male | 42 | IIIA | pT2aN2 | 14/32 | +++ | +++ | ++ | ++ |
16 | Male | 72 | IIIA | pT2aN2 | 7/11 | ++ | +++ | + | + |
17 | Male | 64 | IIB | pT2aN1 | 1/10 | ++ | ++ | + | +++ |
18 | Male | 61 | IIIA | pT2bN2 | 2/10 | +++ | +++ | +++ | +++ |
19 | Male | 65 | IIIB | pT4N2 | 1/32 | +++ | +++ | – | +++ |
20 | Male | 66 | IIIA | pT2bN2 | 4/8 | +++ | ++ | ++ | ++ |
21 | Male | 67 | IIB | pT2aN1 | 2/14 | ++ | +++ | ++ | ++ |
22 | Male | 53 | IIIA | pT2aN2 | 11/23 | +++ | +++ | ++ | +++ |
23 | Male | 59 | IIIA | pT2aN2 | 16/31 | ++ | +++ | ++ | ++ |
24 | Male | 45 | IIIB | pT2aN3 | 8/11 | + | +++ | ++ | +++ |
25 | Male | 60 | IIIA | pT3N2 | 9/35 | +++ | ++ | + | ++ |
26 | Male | 59 | IIIA | pT2aN2 | 7/20 | ++ | +++ | +++ | +++ |
27 | Male | 47 | IIIA | pT2aN2 | 12/18 | ++ | +++ | ++ | + |
28 | Male | 69 | IIIA | pT2bN2 | 2/37 | + | +++ | +++ | ++ |
29 | Male | 57 | IIIA | pT3N1 | 1/11 | + | +++ | ++ | + |
30 | Male | 60 | IIIA | pT2aN2 | 5/11 | ++ | +++ | ++ | ++ |
primary vs.LN | Median score | Median score | Median score | Median score | |||||
<0.001 | 11.10 | 14.57 | 11.29 | 13.58 | |||||
p value | <0.001 | p value | <0.001 |